~~<i id='113832BEC4'><strike id='113832BEC4'><tt id='113832BEC4'><pre id='113832BEC4'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

explore

author：Wikipedia 2025-09-03 03:37:14 - browse：1

An illustration of red blood cells — Adobe

As a boy growing up with hemophilia A, Noah Frederick reserved the end of his annual checkups to talk about new technologies. His doctor walked through various experimental approaches for the bleeding disorder and, invariably, gene therapy. It was coming, he always said, in your lifetime.

Last year, it finally arrived. But Frederick, now a 23-year-old software engineer, isn’t sure he’ll get it. He wants to be part of the sci-fi future gene therapy has always represented, but a recent doctor’s visit left him uncertain.

“I’m on the fence,” he said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Activists slam private health insurers over coverage restrictions

knowledge

focus

entertainment

focus

Wikipedia

WASHINGTON--TheSupremeCourtwillreviewarulingstrikingdownadomesticviolencefederalgunban.

WSS

Walensky prepares to leave CDC — and Congress — behind

How one medical school became remarkably diverse

State Dept. review finds Biden bears some blame for Afghanistan failures

Activists slam private health insurers over coverage restrictions

Duchenne breakthrough therapy leaves behind pioneering families

Affirmative action in medical school literally saved lives

leisure time

explore

knowledge

At least 13 dead in Texas as scorching temps continue

BioMarin wins approval for gene therapy to treat hemophilia A

Psychedelics group wrestles with new pharma identity

Heart attack and stroke risk calculators need revising

In Memoriam: Notable people who died in 2023

What does generative AI mean for health care? We asked experts

State Dept. review finds Biden bears some blame for Afghanistan failures

Peter Hotez and the public health issue of online harassment

As demand for Covid shots wanes, Moderna seeks its next success

Virginia high school admissions case could be legal follow

focus

In age of alternative facts, a scholarly course on calling out crap

Activists slam private health insurers over coverage restrictions

How one medical school became remarkably diverse

Guidelines to prevent youth baseball injuries need more muscle

Alkermes shareholders re

Jerome Adams on the need for new antivirals for Covid

entertainment

focus

focus

Wikipedia